Oxidative Stress Markers in COPD
NCT04748887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2021-02-10
Summary
Background:Striking feature of Chronic obstructive pulmonary disease (COPD) is its inability to resolve after cigarette smoke exposure has ended, which has contributed to the possibility that the disease could also be driven by other endogenous causes, such as autoimmunity or chronic infection . Many of the pathogenetic pathways involved in COPD and its development tend to be driven by oxidative stress.
Conditions
- Role of Oxidative Stress in COPD
Interventions
- OTHER
-
oxidative stess markers
markers of oxidative stress , Superoxide Dismutase (SOD) and Malondialdehyde (MDA) by ( ELISA Kit SinoGeneClon Biotech Co.,Ltd Catalog No : SG- 10188) .
Sponsors & Collaborators
-
Minia University
lead OTHER
Principal Investigators
-
zainab H Saeed, MD · MD chest diseases
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2019-04-01
- Completion
- 2019-09-01
Countries
- Egypt
More Related Trials
-
Oxidative Damage and Antioxidant Mechanisms in COPD
NCT02406053 ·Status: COMPLETED
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Clinical Features and Airways Inflammation in Never Smokers and Smokers With COPD
NCT03274791 ·Status: COMPLETED
-
Assessment of Trace Elements, Systemic Inflammation and Electrolytes
NCT05718453 ·Status: COMPLETED ·Phase: PHASE1
-
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)
NCT01398943 ·Status: COMPLETED ·Phase: NA
-
Factors That Affect the Development of COPD Symptoms
NCT00740337 ·Status: COMPLETED
-
Markers of COPD Exacerbations
NCT05315674 ·Status: RECRUITING
-
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
NCT06518473 ·Status: RECRUITING
-
Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
NCT06826560 ·Status: COMPLETED
-
Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD
NCT02346604 ·Status: COMPLETED
-
The Role of Computed Tomography in the Phenotyping of COPD Patients
NCT05747235 ·Status: COMPLETED
-
Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease
NCT05214508 ·Status: COMPLETED ·Phase: NA
-
Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
NCT03400839 ·Status: UNKNOWN
-
Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients
NCT02719145 ·Status: COMPLETED
-
Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis
NCT06974799 ·Status: COMPLETED
-
Nutritional Enhancement in Chronic Obstructive Pulmonary Disease (COPD)
NCT00884299 ·Status: COMPLETED ·Phase: NA
-
Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)
NCT04474717 ·Status: COMPLETED ·Phase: NA
-
Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
NCT00889447 ·Status: COMPLETED
-
Predictors of Acute Exacerbation in Patients With COPD - an Observational Study
NCT04140097 ·Status: ACTIVE_NOT_RECRUITING
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440 ·Status: RECRUITING
-
Biomarkers for Diagnosis and Treatment of COPD
NCT02633280 ·Status: COMPLETED
-
Comparison of Water Sorption Capacity and the Composition of Bronchial Fluids of Healthy Persons and Patients With Chronic Obstructive Bronchitis (COPD)
NCT04703023 ·Status: COMPLETED
-
A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
NCT01219946 ·Status: COMPLETED
-
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02827721 ·Status: UNKNOWN